Thomas Jang (@tomjanguroonc) 's Twitter Profile
Thomas Jang

@tomjanguroonc

Chief of Urologic Oncology @RutgersCancer; Urology Residency Program Director @rwjurology

ID: 938459144801210378

linkhttps://www.cinj.org/thomas-jang-md-mph-facs calendar_today06-12-2017 17:24:30

646 Tweet

1,1K Followers

1,1K Following

Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

How much do you know about blue light cystoscopy? 🤔 Learn more about how blue light cystoscopy is used to help patients with #bladdercancer with Rutgers Cancer Institute and RWJBarnabas's Dr. Vignesh Packiam. Vignesh Packiam, MD Robert Wood Johnson University Hospital #BladderCancerAwarenessMonth #bladdercancerawareness

Vignesh Packiam, MD (@vigneshpackiam) 's Twitter Profile Photo

Always fun to chat with Sam S. Chang MD, MBA! More data supporting non-risk adapted use of Gem/Doce - consistent efficacy in a variety of stages and grades of NMIBC Raises question of utility of maintenance especially in low grade disease Saum Ghodoussipour Rutgers Cancer Institute Rutgers RWJ Urology Ian McElree

UroToday.com (@urotoday) 's Twitter Profile Photo

Sequential gemcitabine and docetaxel show promise for intermediate-risk #NMIBC. Vignesh Packiam, MD Rutgers RWJ Urology joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss the emerging role of intravesical gem/doce for treating #NMIBC. #WatchNow > bit.ly/4aeVRiU

Sequential gemcitabine and docetaxel show promise for intermediate-risk #NMIBC. <a href="/VigneshPackiam/">Vignesh Packiam, MD</a> <a href="/rwjurology/">Rutgers RWJ Urology</a> joins <a href="/UroCancerMD/">Sam S. Chang MD, MBA</a> <a href="/VUMCurology/">Vanderbilt Urology</a> to discuss the emerging role of intravesical gem/doce for treating #NMIBC. #WatchNow &gt; bit.ly/4aeVRiU
Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

Watch Rutgers Cancer Institute's Dr. Vignesh Packiam Vignesh Packiam, MD weigh multiple recent studies that explore the efficacy of gemcitabine/docetaxel as a frontline therapy for upper tract urothelial #carcinoma. guoncologynow.com/post/sequentia… RWJBarnabas #UroOnc #Chemotherapy #KidneyCancer

UroToday.com (@urotoday) 's Twitter Profile Photo

Sequential gemcitabine and docetaxel show promise for intermediate-risk #NMIBC. Vignesh Packiam, MD Rutgers RWJ Urology joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss the emerging role of intravesical gem/doce for treating #NMIBC. #WatchNow > bit.ly/4aeVRiU

Sequential gemcitabine and docetaxel show promise for intermediate-risk #NMIBC. <a href="/VigneshPackiam/">Vignesh Packiam, MD</a> <a href="/rwjurology/">Rutgers RWJ Urology</a> joins <a href="/UroCancerMD/">Sam S. Chang MD, MBA</a> <a href="/VUMCurology/">Vanderbilt Urology</a> to discuss the emerging role of intravesical gem/doce for treating #NMIBC. #WatchNow &gt; bit.ly/4aeVRiU
NJMS Urology (@njmsurology) 's Twitter Profile Photo

Yesterday we had the opportunity to participate in a cadaveric dry lab for IPP, AUS and male sling placement all thanks to Boston Scientific Urology and the attendings that participated Chrystal Chang, MD Amjad Alwaal and Danielle Velez ! We also appreciate the chance to hang with Rutgers RWJ Urology team!

Yesterday we had the opportunity to participate in a cadaveric dry lab for IPP, AUS and male sling placement all thanks to <a href="/bsc_urology/">Boston Scientific Urology</a> and the attendings that participated <a href="/CChangUro/">Chrystal Chang, MD</a> <a href="/amjad_alwaal/">Amjad Alwaal</a> and <a href="/DrDaniVelez/">Danielle Velez</a> ! 

We also appreciate the chance to hang with <a href="/rwjurology/">Rutgers RWJ Urology</a> team!
Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

Join Rutgers Cancer Institute & RWJBarnabas's Dr. Saum Ghodoussipour Saum Ghodoussipour as he discusses ctDNA in Non-Muscle Invasive Bladder Cancer: Screening & Prognosis with UroToday.com. urotoday.com/video-lectures… #BladderCancer #BladderCancerScreening #CancerScreening